What is the Role of Midodrine in Patients with Decompensated Cirrhosis?
- PMID: 21475424
- PMCID: PMC3061021
What is the Role of Midodrine in Patients with Decompensated Cirrhosis?
References
-
- Kashani A, Landavere C, Medici V, Rossaro L. Fluid retention in cirrhosis: pathophysiology and management. QJM. 2008;101:71–85. - PubMed
-
- Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7:122–128. - PubMed
-
- Moreau R, Lebrec D. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond. Hepatology. 2006;43:385–394. - PubMed
-
- Tandon P, Tsuyuki RT, Mitchell L, et al. The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study. Liver Int. 2009;29:169–174. - PubMed
-
- Kalambokis G, Fotopoulos A, Economou M, Pappas K, Tsianos EV. Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites. J Hepatol. 2007;46:213–221. - PubMed
LinkOut - more resources
Full Text Sources